Clinical trial
Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for the Management of Inflammation and Pain After Phacoemulsification Compared to Prednisolone Acetate 1%.
NCT03693989 is registered in ClinicalTrials.gov with Laboratorios Sophia S.A de C.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for the Management of Inflammation and Pain After Phacoemulsification Compared to Prednisolone Acetate 1%.
- Lead sponsor
- Laboratorios Sophia S.A de C.V.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 4, 2018
- Completion date
- October 22, 2019
- Enrollment
- 178 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.